Insiders Only Get Paid if BioLargo 4x’s - Locked-Up Shares Tied to $40M Revenue or $300M Market Cap vs. Today’s ~$60M

This is massively bullish: the CEO only gets this chunk of pay if BioLargo’s revenue or market cap *explodes* from here. ## Skin in the game - The president just took 130,222 new shares at 0.1843 **instead** of cash salary and reimbursements, taking his total beneficial ownership to 10,523,625 shares. - Those shares are locked until BioLargo prints at least 40 million in revenue in any reported period, hits a 300 million market cap, or there’s a change of control. ## What it signals - Management is literally betting delayed salary and out‑of‑pocket expenses on BioLargo doing a 4x+ from here, not on some small bounce. - It’s the opposite of a “cash‑out”; it’s an all‑in leverage move that only pays if real business performance forces a re‑rating. ## Future vibes - Imagine when the trigger hits: 40M+ revenue on the tape or a 300M+ cap, with insiders unlocking millions of shares because the thesis actually played out. - The best part is that for retail, those “vibes” arrive *before* they can even sell these locked shares, meaning the runway to those levels belongs first to the open market.